SOPHiA GENETICS (SOPH) Return on Sales (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Return on Sales data on file, last reported at 0.01% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
• Return on Sales improved to 0.01% in Q4 2025, from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2024 to a low of 0.48% in Q3 2021.
• A 5-year average of 0.04% and a median of 0.01% in 2021 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales plunged 47 bps in 2021 and jumped 46 bps in 2022, its largest moves.
• Tracing SOPH's Return on Sales over 5 years: stood at 0.02% in 2021, then surged by 47 bps to 0.01% in 2022, then tumbled by 33 bps to 0.01% in 2023, then jumped by 44 bps to 0.01% in 2024, then slipped by 17 bps to 0.01% in 2025.
• Business Quant data shows SOPH's Return on Sales at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.